Poltreg S.A.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Poltreg S.A. is a biotechnology company based in Poland that focuses on developing innovative therapies for autoimmune diseases. The company specializes in using T-regulatory cells (TREGs) to develop a new generation of medicines aimed at treating autoimmune diseases , such as diabetes type 1 and multiple sclerosis. Poltreg S.A. is currently conducting various stages of research and development projects in these areas to offer medical solutions to those suffering from autoimmune diseases . The company's strong commitment to research and development is reinforced by its team of qualified scientists and researchers dedicated to developing new technologies and techniques to improve health outcomes.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-13 15:56 |
Capital/Financing Update
Rejestracja spółki zależnej Immuthera w USA - Content (PL)
|
Polish | 784 bytes | |
| 2025-05-21 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Zgromadze…
|
Polish | 2.3 KB | |
| 2025-05-20 22:12 |
Regulatory News Service
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.4 KB | |
| 2025-05-20 22:12 |
Regulatory News Service
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.3 KB | |
| 2025-05-20 15:45 |
Remuneration Report
Sprawozdanie RN o wynagrodzeniach
|
Polish | 1.2 MB | |
| 2025-05-20 15:45 |
Declaration of Voting Results & Voting Rights Announcements
Podjęte Uchwały
|
Polish | 184.3 KB | |
| 2025-05-20 15:45 |
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie PolTREG S.A. w dniu 2…
|
Polish | 729 bytes | |
| 2025-05-19 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.6 KB | |
| 2025-05-19 11:17 |
Board/Management Change
CV
|
Polish | 1.2 MB | |
| 2025-05-19 11:17 |
Board/Management Change
Zgłoszenie kandydata na Członka Rady Nadzorczej PolTREG S.A. - Content (PL)
|
Polish | 1.7 KB | |
| 2025-05-18 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.5 KB | |
| 2025-05-14 17:20 |
Quarterly Report
Raport kwartalny 1Q 2025
|
Polish | 4.4 MB | |
| 2025-05-06 10:53 |
Regulatory News Service
Otrzymanie pozytywnej opinii od Komitetu Pediatrycznego Europejskiej Agencji Le…
|
Polish | 1.3 KB | |
| 2025-05-05 10:13 |
Inside Information Statement
Otrzymanie raportu z części in vivo badań na zwierzętach w programie terapii CA…
|
Polish | 1.0 KB | |
| 2025-04-29 16:01 |
Regulatory News Service
Negatywna ocena projektu badawczo-rozwojowego PolTREG S.A. przez Polską Agencję…
|
Polish | 1.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |